Document Detail

Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form.
MedLine Citation:
PMID:  17498396     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Mycophenolic acid (MPA), an immunosuppressant, is excreted as its glucuronized form, MPAG. In humans, MPAG is mostly excreted into urine, whereas more than 80% of the dose is excreted into bile in rats. The aim of this study was to clarify the cause of the species difference. We investigated whether MPAG is a substrate of human organic anion transporters (hOATs), and we compared the affinities of multi-drug resistance-associated protein 2 (MRP2) for MPAG in rats and humans. METHODS: The inhibitory effects of MPAG on the uptake of typical substrates via hOAT1 and hOAT3 were determined using HeLa cells heterologously expressing hOAT1 and Xenopus laevis oocytes heterologously expressing hOAT3. MPAG transport activity via hOAT1 and hOAT3 was determined by the two-microelectrode voltage-clamp technique using Xenopus laevis oocytes expressing hOAT1 and hOAT3. The affinities of MPAG for hMRP2 and rMrp2 were determined by the inhibitory effects of MPAG on p-aminohippuric acid (a typical substrate) uptake using membrane vesicles expressing hMRP2 or rMrp2. RESULTS: MPAG inhibited the uptake of PAH via hOAT1 and hOAT3, and calculated IC50 values were 222.6+/-26.6 microM and 41.5+/-11.5 microM, respectively. However, MPAG was not transported by hOAT1 and hOAT3. MPAG strongly inhibited the uptake of PAH via both rMrp2 and hMRP2. However, the magnitudes of inhibitory effects were different. The calculated IC50 values were 286.2+/-157.3 microM and 1036.8+/-330.5 microM, respectively. CONCLUSION: MPAG is not a substrate but is an inhibitor of hOAT1 and hOAT3. The affinity of rMRP2 to MPAG was about 3.6 times as high as that of hMRP2. Therefore, the difference of affinity between hMRP2 and rMrp2 is a possible mechanism of the difference of excretion ratio of MPAG between rats and human.
Yoh Takekuma; Haruka Kakiuchi; Koujiro Yamazaki; Seiji Miyauchi; Takashi Kikukawa; Naoki Kamo; Vadivel Ganapathy; Mitsuru Sugawara
Related Documents :
16618416 - Targeted deletion of fatp5 reveals multiple functions in liver metabolism: alterations ...
833146 - Transport of amino acids in renal brush border membrane vesicles. uptake of l-proline.
10484816 - Further observations on the uptake and effects of phosphonates in perfused rat liver st...
7102556 - Myocardial metabolic alterations after contrast angiography.
20950596 - Altered amino acid homeostasis and the development of fatigue by breast cancer radiothe...
11165086 - Pluronic f-127 gels incorporating highly purified unsaturated fatty acids for buccal de...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques     Volume:  10     ISSN:  1482-1826     ISO Abbreviation:  J Pharm Pharm Sci     Publication Date:  2007  
Date Detail:
Created Date:  2007-05-14     Completed Date:  2007-05-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9807281     Medline TA:  J Pharm Pharm Sci     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  71-85     Citation Subset:  IM    
Laboratory of Pharmcotherapeutic Information, Faculty of Pharmaceutical Science, Hokkaido University, Sapporo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bile / metabolism
Glucuronides / metabolism*
Hela Cells
Immunosuppressive Agents / pharmacokinetics*
Membrane Transport Proteins / metabolism*
Multidrug Resistance-Associated Proteins / metabolism*
Mycophenolic Acid / pharmacokinetics*
Organic Anion Transport Protein 1 / physiology
Organic Anion Transporters, Sodium-Independent / physiology
Rats, Wistar
Species Specificity
Xenopus laevis
p-Aminohippuric Acid / pharmacokinetics
Reg. No./Substance:
0/Glucuronides; 0/Immunosuppressive Agents; 0/Membrane Transport Proteins; 0/Multidrug Resistance-Associated Proteins; 0/Organic Anion Transport Protein 1; 0/Organic Anion Transporters, Sodium-Independent; 0/multidrug resistance-associated protein 2; 0/organic anion transport protein 3; 24280-93-1/Mycophenolic Acid; 61-78-9/p-Aminohippuric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Enhanced nuclear delivery and cytotoxic activity of hydroxycamptothecin using o/w emulsions.
Next Document:  Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon.